Клиническое исследование

Optimizing Y90 Therapy for Radiation Lobectomy

NCT: NCT04390724 · ACTIVE_NOT_RECRUITING

NCT IDNCT04390724

СтатусACTIVE_NOT_RECRUITING

Дата начала2020-07-17

Завершение2026-11-27

SponsorNorthwestern University (OTHER)

First posted2020-05-15

Last updated2026-09-16

Краткое описание

HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.

Официальный источник

Открыть на ClinicalTrials.gov →

Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.